Drawing for TRIO

USPTO serial 98178586

TRIO

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
GAYNOR, BARBARA ANNE
Law office
TMO LAW OFFICE 115

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with TRIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kim Cooper

Kim Cooper GREENBERG TRAURIG10845 GRIFFITH PEAK DRIVE STE. 600LAS VEGAS, NV 89135United States

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic at-home health test and screening kits comprised of medical diagnostic reagents for testing of bodily fluids for use in determining the presence of medical conditions and levels of biomarkers; diagnostic test cartridges in the nature of diagnostic test reagents for medical purposes for use in determining the presence of medical conditions and levels of biomarkers; direct-to-consumer diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in microbiome, fertility, hormone, and biomarker testing of humans; none of the aforesaid relating to thermal analysis and rheology instrumentsACTIVE—
009Direct-to-consumer diagnostic test kits comprising a downloadable software application for use in analyzing microbiome, fertility, hormone, and biomarker testing of humans; scientific research specimen collection devices in the nature of cartridges and rigid and semi-rigid containers for the collection of saliva and bodily fluids for use in analyzing microbiome, fertility, hormone, and biomarker testing of humans; laboratory storage test cartridges used to store laboratory samples for use in analyzing microbiome, fertility, hormone, and biomarker testing of humans; medical laboratory research instruments for testing of bodily fluids and detecting the levels of biomarkers; downloadable software for health and medical data storage, data analysis, and report generation for analyzing microbiome, fertility, hormone, and biomarker information; downloadable software for recording, storing, and organizing cellular, molecular, physiological, and medical data for analyzing microbiome, fertility, hormone, and biomarker information; downloadable software for analyzing microbiome, fertility, hormone, and biomarker information for medical diagnostic purposes; downloadable software for display and communication of medical information, remote patient monitoring and providing telehealth and digital medical services for analyzing microbiome, fertility, hormone, and biomarker information; none of the aforesaid relating to thermal analysis and rheology instrumentsACTIVE—
010Direct-to-consumer medical diagnostic test kits comprised of probes, buffers, and reagents for use in microbial testing and microbiome, fertility, hormone, and biomarker testing of humans; medical testing apparatus, instruments, and devices for diagnostic use, namely, apparatus, instruments, and devices for medical diagnostic testing through the collection and analysis of body fluids, biomarkers, fertility, and hormone levels; medical instruments for taking samples for review for medical diagnostic purposes; lab test cartridges for medical testing purposes; medical devices, instruments, and apparatus for obtaining body fluid samples; saliva collection devices for medical purposes; sterile medical specimen collection tools in the nature of cartridges and rigid and semi-rigid containers for the collection of saliva and bodily fluids; none of the aforesaid relating to thermal analysis and rheology instrumentsACTIVE—
042Providing scientific research information and analysis in the fields of microbiomes, fertility, hormone levels, and biomarkers; providing medical research information in the field of testing results for medical conditions; Software as a Service (SaaS) featuring software for health and medical data storage, data analysis, and report generation for medical diagnostic purposes; Software as a Service (SaaS) featuring software for recording, storing, and organizing cellular, physiological and molecular data for medical diagnostic purposes; Software as a Service (SaaS) featuring software for analyzing microbiome, fertility, hormone, and biomarker information for medical diagnostic purposes; Software as a Service (SaaS) featuring software for display and communication of medical information, remote patient monitoring and providing telehealth and digital medical services; none of the aforesaid relating to medical and clinical research in the field of oncology; none of the aforesaid relating to thermal analysis and rheology instrumentsACTIVE—
044Medical diagnostic testing, monitoring and reporting services, namely, providing testing, monitoring and reporting services using self-collected samples outside of a clinical laboratory setting; providing medical information in the field of microbiome, fertility, hormone, and biomarker testing of humans; none of the aforesaid relating to medical and clinical research in the field of oncology; none of the aforesaid relating to thermal analysis and rheology instrumentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Mar 17, 2025MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 17, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 26, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Sep 26, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Aug 29, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 6, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 6, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 9, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2024DOCKASSIGNED TO EXAMINER—
Oct 3, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 16, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance